Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$12.2 - $16.75 $3.66 Million - $5.03 Million
-300,399 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$12.03 - $17.51 $1.08 Million - $1.57 Million
-89,601 Reduced 22.97%
300,399 $4.23 Million
Q1 2021

May 14, 2021

BUY
$15.54 - $21.32 $6.06 Million - $8.31 Million
390,000 New
390,000 $6.3 Million

About Finch Therapeutics Group, Inc.


  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $572M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.